Compare Oruka Therapeutics Inc. Common Stock (ORKA) vs Weibo Corp (WB) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Oruka Therapeutics Inc. Common Stock vs Weibo Corp — how do they compare? Oruka Therapeutics Inc. Common Stock trades at $75.5 (market cap $5.08B), while Weibo Corp trades at $6.59 (market cap $1.62B). The key difference: Oruka Therapeutics Inc. Common Stock is far larger — about 3.1× Weibo Corp's market cap, and Weibo Corp pays a 9.36% dividend while Oruka Therapeutics Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Oruka Therapeutics Inc. Common Stock for 0 Days and Weibo Corp for 103 Days on average.
| ORKA | WB | |
|---|---|---|
Market Cap | $5.08B | $1.62B |
Volume | 685,276 | 835,309 |
Sector | Health | Media |
52-Week High | $113.08 | $11.52 |
52-Week Low | $26.19 | $6.33 |
Typical Hold Time | 0 Days | 103 Days |
Enterprise Value | $4.21B | $849.15M |
Dividend Yield | — | 9.36% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Weibo (WB) trades at $6.56 with modest daily gains of 0.23%. The stock shows mixed technical signals with a bearish overall trend but neutral oscillators. Fundamentally, WB maintains strong profitability with 73.36% gross margins and attractive valuation ratios including a P/E of 5.38 and P/B of 0.4. Recent earnings show volatility with Q2 2026 beating expectations but Q1 and Q4 2025 missing estimates. Cash flow trends indicate operational stability despite negative net cash flow in 2024.
WB presents as a deep-value opportunity with compelling valuation metrics and solid profitability, though growth concerns persist. Investment appeal centers on low multiples and strong cash generation, countered by declining user metrics and advertising headwinds. Analyst consensus leans neutral with 40.91% buy ratings, reflecting cautious optimism amid competitive pressures in China's social media landscape.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Oruka Therapeutics Inc. Common Stock
Oruka Therapeutics, Inc. is a clinical-stage biotechnology company developing extended half-life monoclonal antibodies for plaque psoriasis, psoriatic arthritis, and related dermatologic conditions, with lead candidates ORKA-001 and ORKA-002 in clinical trials.
Read more on ORKA →About Weibo Corp
Weibo is the largest social media platform in China. As of 2020, Weibo had 521 million monthly active users and 225 million daily active users, many of whom are drawn there by the millions of key opinion leaders in entertainment, sports, and business circles. Sina is the major shareholder, holding 44.7% of shares and with 70.8% voting power.
Read more on WB →
